Steven Ryder

CIK: 0001872868

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

YARW

Yarrow Bioscience, Inc.

Officer

MBX

MBX Biosciences, Inc.

Director

RLYB

Rallybio Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

YARW
Yarrow Bioscience, Inc.
Oct 29, 2026
Award(A)
Stock Option (Right to Buy)
Direct
113.1K shares-
MBX
MBX Biosciences, Inc.
Jun 4, 2026
Award(A)
Stock option (right to buy)
Direct
12.5K shares-
MBX
MBX Biosciences, Inc.
Jun 5, 2025
Award(A)
Stock option (right to buy)
Direct
16K shares-
RLYB
Rallybio Corp
Feb 14, 2025
Award(A)
Option (Right to Buy)
Direct
180K shares-
MBX
MBX Biosciences, Inc.
Sep 12, 2024
Award(A)
Stock Option (Right to Buy)
Direct
16K shares-

		Type	Shares	Price		Ownership
Oct 29, 2026	YARW Yarrow Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	113,137	-	-	Direct
Jun 4, 2026	MBX MBX Biosciences, Inc.	Award(A) Stock option (right to buy)	12,500	-	-	Direct
Jun 5, 2025	MBX MBX Biosciences, Inc.	Award(A) Stock option (right to buy)	16,000	-	-	Direct
Feb 14, 2025	RLYB Rallybio Corp	Award(A) Option (Right to Buy)	180,000	-	-	Direct
Sep 12, 2024	MBX MBX Biosciences, Inc.	Award(A) Stock Option (Right to Buy)	15,963	-	-	Direct

1-5 of 5 transactions

About Ryder Steven

Ryder Steven (SEC CIK 0001872868) files insider reports with the SEC as Chief Medical Officer of Yarrow Bioscience, Inc. (YARW), Director of MBX Biosciences, Inc. (MBX) and Chief Medical Officer of Rallybio Corp (RLYB).

Signal8 holds 7 ownership filings by Ryder Steven (2 Form 3, 5 Form 4), filed between Sep 12, 2024 and Oct 30, 2026. Those filings report 5 transactions, from Sep 12, 2024 to Oct 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ryder Steven's filings is in NEW HAVEN, CT.

Recent filings by Ryder Steven

Oct 29, 2026: Grant or award of YARW derivative securities (Form 4, code A).
Jun 4, 2026: Grant or award of MBX derivative securities (Form 4, code A).
Jun 5, 2025: Grant or award of MBX derivative securities (Form 4, code A).
Feb 14, 2025: Grant or award of RLYB derivative securities (Form 4, code A).
Sep 12, 2024: Grant or award of MBX derivative securities (Form 4, code A).

Other insiders filing for Yarrow Bioscience, Inc. (YARW)

Payton Lori, Chief Development Officer
Alford Rachael, Chief Operating Officer
Frey Rebecca, Chief Executive Officer
Zeronda Tyler, Chief Financial Officer
RTW Fund Group GP, LLC, 10% Owner
Ashiya Mona, Director

How to read Form 4 transaction codes